Staeheli Sandra N, Baumgartner Markus R, Gauthier Saskia, Gascho Dominic, Jarmer Juliane, Kraemer Thomas, Steuer Andrea E
Department of Forensic Pharmacology & Toxicology, Zurich Institute of Forensic Medicine, University of Zurich, Switzerland.
Center for Forensic Hairanalytics, Zurich Institute of Forensic Medicine, University of Zurich, Switzerland.
Forensic Sci Int. 2016 Sep;266:170-177. doi: 10.1016/j.forsciint.2016.05.034. Epub 2016 Jun 3.
A fatal case of butyrfentanyl poisoning was investigated at the Zurich Institute of Forensic Medicine. At admission at the institute approx. 9h after death (first time point, t1), femoral and heart blood (right ventricle) was collected, as well as samples from the lung, liver, kidney, spleen, muscle and adipose tissue using computed tomography (CT)-guided biopsy sampling. At autopsy (t2), samples from the same body regions were collected manually. Additionally, urine, heart blood (left ventricle), gastric content, brain samples and hair were collected. Butyrfentanyl concentrations and relative concentrations of the metabolites carboxy-, hydroxy-, nor-, and desbutyrfentanyl were determined by LC-MS/MS and LC-QTOF. At t1, butyrfentanyl concentrations were 66ng/mL in femoral blood, 39ng/mL in heart blood, 110ng/g in muscle, 57ng/g in liver, 160ng/g in kidney, 3100ng/g in lung, 590ng/g in spleen and 550ng/g in adipose tissue. At t2, butyrfentanyl concentration in urine was 1100ng/mL, in gastric content 2000ng/mL, in hair 11,000pg/mg and brain concentrations ranged between 200-340ng/g. Carboxy- and hydroxybutyrfentanyl were identified as most abundant metabolites. Comparison of t1 and t2 showed a concentration increase of butyrfentanyl in femoral blood of 120%, in heart blood of 55% and a decrease in lung of 30% within 19h. No clear concentration changes could be observed in the other matrices. Postmortem concentration changes were also observed for the metabolites. In conclusion, butyrfentanyl seems to be prone to postmortem redistribution processes and concentrations in forensic death cases should be interpreted with caution.
苏黎世法医学研究所对一例丁酰芬太尼中毒致死病例进行了调查。在该研究所入院时,即死亡后约9小时(第一个时间点,t1),采集了股血和心脏血(右心室),并使用计算机断层扫描(CT)引导下的活检采样方法,从肺、肝、肾、脾、肌肉和脂肪组织采集了样本。在尸检时(t2),手动采集了相同身体部位的样本。此外,还采集了尿液、心脏血(左心室)、胃内容物、脑样本和毛发。通过液相色谱-串联质谱法(LC-MS/MS)和液相色谱-四极杆飞行时间质谱法(LC-QTOF)测定丁酰芬太尼浓度以及代谢物羧基-、羟基-、去甲-和去丁酰芬太尼的相对浓度。在t1时,股血中丁酰芬太尼浓度为66ng/mL,心脏血中为39ng/mL,肌肉中为110ng/g,肝脏中为57ng/g,肾脏中为160ng/g,肺中为3100ng/g,脾脏中为590ng/g,脂肪组织中为550ng/g。在t2时,尿液中丁酰芬太尼浓度为1100ng/mL,胃内容物中为2000ng/mL,毛发中为11,000pg/mg,脑浓度在200 - 340ng/g之间。羧基-和羟基丁酰芬太尼被鉴定为最主要的代谢物。t1和t2的比较显示,在19小时内,股血中丁酰芬太尼浓度增加了120%,心脏血中增加了55%,肺中减少了30%。在其他基质中未观察到明显的浓度变化。代谢物也观察到了死后浓度变化。总之,丁酰芬太尼似乎易于发生死后再分布过程,在法医死亡案件中的浓度应谨慎解释。